- Patient identification: how to find patients who are eligible to participate in your rare disease trial
- Collaborating with patient advocacy groups to facilitate recruitment
- How does recruitment in rare diseases differ from other therapeutic areas?
- Using eConsent as a tool to speed up recruitment and thus overall trial timelines
- The regulatory landscape surrounding eConsent: what challenges are there to this?
- Maintaining a relationship with patients in order to ensure consent is informed in remote settings
- Reviewing results from our annual survey: were 2024 predictions correct?
- Key themes and technology advancements in biopharma
- Spotlight on clinical trial technologies for drug development
- Leveraging data to predict the outlook for 2025 clinical trial outsourcing
- Trends, key players, opportunities and threat in biopharma
- What the latest investment trends show for small to medium biotechs
- How successful collaboration with advocacy groups can boost recruitment and enrolment
- Strategies for building effective partnerships with advocacy groups
- Utilizing patient-centric approaches to enhance trial recruitment efforts
- The impact of a patient-focused trial design on accelerating timelines
